Mandom Corp

Mandom Corp maintains a strong liquidity position, with a current ratio of 4.04, indicating the company can easily cover its short-term liabilities with its current assets. The company's liquidity_fpt score further supports this, showing a low liquidity risk. Additionally, Mandom Corp holds JPY 29.12 billion in cash and equivalents, which provides a significant buffer against short-term obligations. In terms of profitability, Mandom Corp's return on equity (ROE) is 2.66%, and its return on assets (ROA) is 1.91%. These figures are below the industry median for personal care products, suggesting that the company is underperforming in terms of capital efficiency and asset utilization. The operating margin is 13.4%, which is in line with the industry average, but the net margin of 2.44% is relatively low, indicating potential inefficiencies in cost management or pricing power. Mandom Corp's revenue is concentrated in Japan, with the majority of its sales derived from domestic operations. The company has limited exposure to international markets, which may limit its growth potential and increase its vulnerability to domestic economic fluctuations. The company's product portfolio is primarily focused on personal care, with no significant diversification into other consumer goods segments. Looking ahead, Mandom Corp's revenue is expected to remain stable, with no significant growth or decline projected in the current or next fiscal year. The company's capital expenditure is negative, indicating a reduction in investment in physical assets, which may signal a focus on cost control or a shift toward digital or service-based offerings. The company's free cash flow of JPY 2.18 billion provides flexibility for dividends, share repurchases, or strategic investments. Mandom Corp's risk assessment indicates a low probability of dilution and no immediate liquidity concerns. The company's debt-to-equity ratio is 0.01, reflecting a conservative capital structure with minimal reliance on debt financing. No significant risk factors were identified in recent filings, and the company has not issued any new shares in the past year. Recent events, including quarterly earnings reports and investor presentations, have not revealed any material changes in the company's strategic direction or financial performance. The company continues to focus on its core personal care products and has not announced any major product launches or market expansions.